Xtant Days Sales Outstanding from 2010 to 2025

XTNT Stock  USD 0.59  0.07  13.46%   
Xtant Medical Days Sales Outstanding yearly trend continues to be comparatively stable with very little volatility. Days Sales Outstanding will likely drop to 73.43 in 2025. From the period from 2010 to 2025, Xtant Medical Days Sales Outstanding quarterly data regression had r-value of  0.16 and coefficient of variation of  26.89. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
95.31
Current Value
73.43
Quarterly Volatility
17.823409
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many indicators such as Price To Sales Ratio of 1.61, Dividend Yield of 0.0 or PTB Ratio of 2.86. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
Check out the analysis of Xtant Medical Correlation against competitors.

Latest Xtant Medical's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Xtant Medical Holdings over the last few years. It is Xtant Medical's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Pretty Stable
   Days Sales Outstanding   
       Timeline  

Xtant Days Sales Outstanding Regression Statistics

Arithmetic Mean66.29
Geometric Mean64.08
Coefficient Of Variation26.89
Mean Deviation15.78
Median68.34
Standard Deviation17.82
Sample Variance317.67
Range49.5754
R-Value0.16
Mean Square Error331.81
R-Squared0.03
Significance0.56
Slope0.59
Total Sum of Squares4,765

Xtant Days Sales Outstanding History

2025 73.43
2024 95.31
2023 82.88
2022 68.34
2021 47.25
2020 47.08
2019 57.13

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Days Sales Outstanding 95.31  73.43 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.